@FierceMedDev: Olympus releases updated endoscope cleaning instructions amid pushback. Story | Follow @FierceMedDev
@EmilyWFierce: ICYMI from FiercePharma: Dr. Reddy's shopping for deals up to $1B as it expands in injectable meds. Report | Follow @EmilyWFierce
> Insulin pump maker Valeritas has postponed its IPO, while one expected from MRI-guided radiation player ViewRay failed to make it out this week as it had planned. More
> The FDA has classified brain injury adjunctive interpretive electroencephalograph (EEG) assessment aids as class II devices. Statement
> The White House has released a plan to combat so-called superbugs, which are bacteria that are resistant to existing antibiotics. It includes the development of next generation diagnostics. More
> The U.S. Department of Defense has renewed a $77.2 million contract for the next year, exercising its sixth year out of 9 one-year option periods. IT is for patient monitoring systems, subsystems, accessories, consumables, spare and repair parts as well as training. Announcement
Biotech News
@FierceBiotech: EuroBiotech Report: Billionaires drive Malin to €330M IPO, Push for EU JOBS Act, RNAi stock jumps on PhIIa data. Read more | Follow @FierceBiotech
@JohnCFierce: ICYMI: Not giving up day job, but interviewing @Asthika from Bloomberg Intelligence on biotech market was fun. Watch | Follow @JohnCFierce
@DamianFierce: Early contender for next year's #FierceMadness: $LLY and Boehringer say Jardiance + metformin = Synjardy. | Follow @DamianFierce
> MorphoSys tanks after Celgene walks away from $818M pact. More
> Novo Nordisk speeds back to the FDA with its once-rejected insulin. Article
> Ohr Pharma's eye drop fails a Phase II AMD trial. Report
Pharma News
@FiercePharma: Jaguar Animal Health eyes a second run at IPO. Story from FierceAnimalHealth | Follow @FiercePharma
@EricPFierce: IPCA says FDA bans will have little sales impact. Didn't Wockhardt make that claim before its profits sank? FiercePharmaManufacturing article | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Hey, European countries--join forces to bring down drug prices, WHO suggests. Article | Follow @CarlyHFierce
> Genentech project to add 100 jobs. News
> Orexigen's Mysimba catches up to Saxenda at EMA finish line. Article